Antidepressants are medications used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, to help manage some addictions. Common side-effects of antidepressants include dry mouth, weight gain, dizziness and sexual dysfunction. Most types of antidepressants are safe to take, but may cause increased thoughts of suicide when taken by children and young adults. A discontinuation syndrome can occur after stopping any antidepressant which resembles recurrent depression; some reviews of antidepressants for depression in adults find benefit. Evidence of benefit in children and adolescents is unclear. There is debate in the medical community about how much of the observed effects of antidepressants can be attributed to the placebo effect. Antidepressants are used to treat major depressive disorder and of other conditions, including some anxiety disorders, some chronic pain conditions, to help manage some addictions. Antidepressants are used in combinations with one another.
The UK National Institute for Health and Care Excellence 2009 guidelines indicate that antidepressants should not be used for the initial treatment of mild depression, because the risk-benefit ratio is poor. The guidelines recommended that antidepressant treatment be considered for: People with a history of moderate or severe depression, Those with mild depression, present for a long period, As a second-line treatment for mild depression that persists after other interventions, As a first-line treatment for moderate or severe depression; the guidelines further note that antidepressant treatment should be used in combination with psychosocial interventions in most cases, should be continued for at least six months to reduce the risk of relapse, that SSRIs are better tolerated than other antidepressants. American Psychiatric Association treatment guidelines recommend that initial treatment should be individually tailored based on factors that include severity of symptoms, co-existing disorders, prior treatment experience, the person's preference.
Options may include pharmacotherapy, electroconvulsive therapy, transcranial magnetic stimulation or light therapy. They recommended antidepressant medication as an initial treatment choice in people with mild, moderate, or severe major depression, that should be given to all people with severe depression unless ECT is planned; some reviews of antidepressants in adults with depression find benefits. Antidepressants are recommended by the National Institute for Health and Care Excellence for the treatment of generalized anxiety disorder that has failed to respond to conservative measures such as education and self-help activities. GAD is a common disorder of which the central feature is excessive worry about a number of different events. Key symptoms include excessive anxiety about multiple events and issues, difficulty controlling worrisome thoughts that persists for at least 6 months. Antidepressants provide a modest-to-moderate reduction in anxiety in GAD; the efficacy of different antidepressants is similar.
Some antidepressants are used as a treatment for social anxiety disorder, but their efficacy is not convincing, as only a small proportion of antidepressants showed some efficacy for this condition. Paroxetine was the first drug to be FDA-approved for this disorder, its efficacy is considered beneficial. Sertraline and fluvoxamine extended release were approved for it as well, while escitalopram is used off-label with acceptable efficacy. However, there isn't enough evidence to support citalopram for treating social phobia, fluoxetine was no better than placebo in clinical trials. SSRIs are used as a first-line treatment for social anxiety. One alternative would be venlafaxine, a SNRI, it showed benefits for social phobia in five clinical trials against placebo, while the other SNRIs are not considered useful for this disorder as many of them didn't undergo testing for it. As of now, it is unclear if duloxetine and desvenlafaxine can provide benefits for social anxiety sufferers. However, another class of antidepressants called MAOIs are considered effective for social anxiety, but they come with many unwanted side effects and are used.
Phenelzine was shown to be a good treatment option. Moclobemide is a RIMA and showed mixed results but still got approval in some European countries for social anxiety disorder. TCA antidepressants, such as clomipramine and imipramine, are not considered effective for this anxiety disorder in particular; this leaves out SSRIs such as paroxetine and fluvoxamine CR as acceptable and tolerated treatment options for this disorder. SSRIs are a second-line treatment of adult obsessive–compulsive disorder with mild functional impairment and as first-line treatment for those with moderate or severe impairment. In children, SSRIs are considered as a second-line therapy in those with moderate-to-severe impairment, with close monitoring for psychiatric adverse effects. SSRIs appear useful for OCD, at least in the short term. Efficacy has been demonstrated both in short-term treatment trials of 6 to 24 weeks and in discontinuation trials of 28 to 52 weeks duration. Clomipramine, a TCA drug, is considered effective and useful for OCD, however it is used as a second line treatment because it is less well tolerated than the SSRIs.
Despite this, it has not shown superiority to fluvoxamine in trials. All SSRIs can be used for OCD, in some cases, SNRIs can be tried though none of them is approved for OCD. However, e
Mobile City Hospital known as Old Mobile General Hospital, is a historic Greek Revival hospital building in Mobile, United States. It was built in 1830 by Thomas S. James and served as a hospital for the city of Mobile from 1831 until 1966, it was administered for the city by the Sisters of Charity throughout a large part of its history. Residents of the city were treated here during epidemics of yellow fever and during the American Civil War, it was converted to office space after 1966. It was added to the National Register of Historic Places on February 26, 1970; the building is adjacent to the old U. S. Marine Hospital, on the National Register; the building is stuccoed brick, with two stories over a raised basement. It features a long colonnaded front facade with a central projecting hexastyle portico supported by full-height Doric columns carrying a full entablature and parapet across the front of the building; the rooms open onto two levels of galleries behind the colonnade
Foluke Daramola-Salako is a Nigerian actress. She was nominated for Africa Movie Academy Award for Best Actress in a Supporting Role in 2013. Daramola was born February 15, she is a graduate of Obafemi Awolowo University. In 1998, she made her film debut in a series titled Palace, she starred in Durodola and Above Law. In 2016, her daughter was reported to be the host of a reality television show, her film, which she produced and starred in got her Africa Movie Academy Awards best supporting actress nomination. She noted that the film was inspired from her personal experiences, as her parents didn't want her to delve into acting while in school, she is the founder of "Action Against Rape in Africa" initiative, a movement that seeks to curb rape and bring its perpetrators to book in Africa. In a 2016 interview, she revealed. In an interview with Tribune, she explained that women needs to be know their value and being financially dependent on their husband, she posited. In 2017, she publicly spoke on the modesty of Aliko Dangote, describing him as "the most humble person on earth".
In a March 2018 interview with The Punch, Daramola-Salako stated that she considers her big boobs to be an asset not a curse: “The first attraction for most men who come across me is sexual. They are moved immediately, but as a person, I would never go out with any man because they are attracted to my boobs because I know that it is too ordinary. As far as I’m concerned, women should stop seeing these ‘assets’ as a problem but take them as a blessing, it is only by so doing. They should carry themselves well and not be ashamed." Foluke Daramola on IMDb
Sheree Atcheson is a Sri Lankan-born Irish computer scientist and Head of Diversity and Inclusion at Monzo. Atcheson has been recognised by Computer Weekly as one of the Most Influential Women in UK Tech, she is the Global Ambassador for Women. Atcheson was born in Sri Lanka. At three weeks old, Atcheson was adopted by a Roman Catholic family in County Tyrone, where she attended St Patrick's Academy, Dungannon; as a child she played computer games with her brother and she decided that she wanted to pursue a career in technology. Her first job was working at the counter at her local pharmacy, she decided to study computer science at Queen's University Belfast. As an undergraduate student, only one in ten of her classmates were women, Atcheson has worked since to address this imbalance. After graduating, Atcheson joined Kainos as a software engineer before joining SR Laboratories. In 2016 Atcheson joined Deloitte, where she worked as a business consultant for strategy and architecture, she was promoted lead for inclusion, helped to design and implement the Deloitte Inclusion Strategy.
At Deloitte, Atcheson led the Consulting practice Inclusion strategy. In 2019 she was appointed Head of Inclusion at Monzo, she has written for The Guardian. And been featured in the Evening Standard, BBC Make It Positive News. Atcheson was involved with establishing United Kingdom expansion of Women. Since launching in 2013, Atcheson has taken their membership to over 8,000 members, over 1,000 of which belong to the Belfast branch, she serves as their Global Ambassador. Atcheson established "I am Lanka", a project set up to champion role models from Sri Lanka. "I am Lanka" began when Atcheson was searching for her birth mother, receiving thousands of messages from Sri Lankan people revealing that she had inspired them to share their stories. She delivered a keynote lecture at the 2018 InspireFest. Atcheson was selected by Computer Weekly as one of the Most Influential Women in UK tech, she was selected by WeAreTheCity as one of the United Kingdom's Rising Stars. In 2019 she was awarded Queen's University Belfast Graduate of the Year. and was listed as one of the Financial Times Top 100 BAME Leaders influencing the Tech sector.
Whilst at Deloitte, she won the Women in Tech Employer of the Year Award in the Women in Tech Employer Awards 2019. Atcheson was married to Sean McCrory on June 4, 2017
In Hindu scriptures, Vena was a great king. However, he became corrupt; the world became so gloomy and dark that the earth-goddess Bhumidevi decided that she would not provide crops to humans anymore. She went into hiding. Meanwhile, a group of Rishis killed Vena out of anger, they rubbed the thigh of his corpse, took out all the evil from his body. Afterwards they rubbed Vena's arm, the good Prithu emerged; this being was Vishnu incarnate, as soon as he was born, Vishnu's Sharanga bow fell from heaven into his hands. However, Bhumidevi still refused to give crops to people; as soon as Prithu, son of Vena, threatened to kill her, she gave in, but in return Prithu would be her eternal guardian. This is why Bhumidevi is known as Prithvi; the sacred literature of the Hindus contains many cases of conflicts between the Brahmins and the Kshatriyas and of sanguinary wards between the two. In the Rigveda, Vena is a personification of a celestial being the rainbow; the name of the hymn is Vena, as is the name of the author of RV 9.85
FK Sūduva is a professional football club based in the city of Marijampolė, Lithuania. Founded in 1968; the club are the defending football champions of Lithuania. The club have been playing in the A Lyga since 2002. In 2006 the team won its first trophy – the Lithuanian Cup, a feat they repeated in 2009. In 2017 Sūduva won the A Lyga for the first time in its history, repeated the triumph in 2018 and 2019; the team's colours are red. The club plays at Hikvision futbolo arena in Marijampolė. 1968 – Sūduva Kapsukas 1993 – Sūduva-Žydrius 1994 – Sūduva Marijampolė Sūduva is one of the oldest and still functioning clubs in Lithuania. It is not so easy to trace its history, as in Soviet times it changed names with every new owner that supported it, it is more or less agreed that this club has existed under the name of Sūduva since 1968. This date known, because was founded Sūduva as football club. During Soviet times it drifted between different local leagues, producing few footballers for the above-mentioned Žalgiris and building a local football community.
Football was actively played in a few smaller towns around Marijampolė, thus making the community of football lovers stronger. It was stronger than the club itself, those who follow the team today are adding to the old tradition; the biggest achievement of the club during Soviet times came in 1975 when Sūduva reached 3rd place at the local top division. The next year it lost the National Cup Final; that was less it. After the dissolution of the Soviet Union Sūduva got few chances to go up, it played the only Baltic championship in 1990 with teams from Lithuania and Estonia. Next year it tried the Lithuanian top division. Both efforts were terrible – Sūduva finished both championships as the last team collecting 7 points at the Baltic championship and only 2 at the Lithuanian league; the team navigated between the 2nd and the 3rd divisions for some 10 years without decent funds or a professional attitude. The worst was the season of 1998 / 1999; the team left it after half a season because it had no funds.
It was not the end. The football traditions were too strong; the team recovered next season at the 3rd division, won it the following year, went up and won again. This rise continues up to this day; the season of 2002 shaped the future. The team reached the top division, it reached the finals of the National Cup and gained the chance to take part in the UEFA Cup. But the most important thing was that it got new owners who were determined to create a functioning and financially predictable club; the European campaign of that year added some good emotions to the general hype. The semi-professional team vanquished Brann from Norway during its first European match and went to Glasgow to meet Celtic; this match was not so successful. Three more seasons at the middle of the table and the team reached 3rd place – 30 years after the achievement of the same caliber. Repeating that history, the club reached the finals of the National Cup the following year. Only this time the Cup went to Marijampolė. Since that year Sūduva have been one of the most stable clubs of the country – both financially and on the league table.
It won the National Cup one more time. It went to play European cups every year receiving teams like Red Bull and Club Brugge; the year 2013 saw a new concept of the team. The budget was still stable but it went down. So the team expressed the wish to put more stress on integration of young local boys into the main team; some important players of the earlier seasons left. So, the year of experiments; the team was much younger, less experienced and weaker. It was many seasons before Sūduva was a clear member of 2–4 teams that were clear leaders of the championship; the question was only about. That year the situation was much tougher for Sūduva, it was clear that the team would need a lot of effort and luck if it wanted to get its traditional silver or bronze. In the 2015 season Sūduva started with a new head coach – Aleksandr Veselinovič; the new coach changed the team style from defending to attacking. In the last season game against Atlantas Sūduva needed at least a draw. Sūduva lost 3rd place to Atlantas.
At the beginning of the 2016 season, Sūduva recalled former team players Marius Činikas and Martynas Matuzas. Multiple A Lyga champions Algis Jankauskas, Andro Švrljuga and Paulius Janušauskas were signed as well. Signed were Croatian goalkeeper Ivan Kardum, Serbian forward Admir Kecap, Bosnian-Herzegovinian defensive midfielder Nermin Jamak and Serbian midfielder Predrag Pavlović. Sūduva finished season 3rd played in Cup final same year. In 2017, FK Sūduva became the first Lithuanian football club after Žalgiris Vilnius and FK Ekranas to pass three qualifying rounds in European competition in 2017–18 Europa League. FK Sūduva eliminated FK Liepāja and FC Sion. In the same season, for the first time, FK Sūduva won A Lyga. In 2018, FK Sūduva played in the 2018–19 UEFA Champions League. In the first round, Sūduva advanced over APOEL FC by scoring 3 consecutive goals in the first 18 minutes of play. In the second qualification round they lost to Red Star Belgrade. After that, they had a chance to play in 2018–19 UEFA Europa League.
Won against FK